These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 7371023

  • 1. Application of a simple competitive protein-binding assay technique to the pharmacokinetics of N-(phosphonacetyl)-L-aspartate in humans.
    Erlichman C, Strong JM, Chabner BA.
    Cancer Res; 1980 Jun; 40(6):1902-6. PubMed ID: 7371023
    [Abstract] [Full Text] [Related]

  • 2. Comparative physiological disposition of N-(phosphonacetyl)-L-aspartate in several animal species after intravenous and oral administration.
    Chadwick M, Silveira DM, MacGregor JA, Branfman AR, Liss RH, Yesair DW.
    Cancer Res; 1982 Feb; 42(2):627-32. PubMed ID: 7055806
    [Abstract] [Full Text] [Related]

  • 3. Long-term association of N-(phosphonacetyl)-L-aspartate with bone.
    Ardalan B, Kensler TW, Jayaram HN, Morrison W, Choie DD, Chadwick M, Liss R, Cooney DA.
    Cancer Res; 1981 Jan; 41(1):150-6. PubMed ID: 7448755
    [Abstract] [Full Text] [Related]

  • 4. Binding of radiolabeled N-(phosphonacetyl)-L-aspartate to aspartate transcarbamylase from Ehrlich ascites tumor cells.
    White JC, Hines LH.
    Biochem Pharmacol; 1984 Nov 15; 33(22):3645-8. PubMed ID: 6508821
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological disposition of N-(phosphonacetyl)-L-aspartate in humans.
    Loo TL, Friedman J, Moore EC, Valdivieso M, Marti JR, Stewart D.
    Cancer Res; 1980 Jan 15; 40(1):86-90. PubMed ID: 7349907
    [Abstract] [Full Text] [Related]

  • 6. A facile enzymatic technique for the estimation of nanomolar concentrations of N-phosphonacetyl-L-aspartic acid in plasma.
    Kensler TW, Jayaram HN, Cooney DA.
    J Biochem Biophys Methods; 1980 Jan 15; 2(1):29-35. PubMed ID: 6999068
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartate.
    Moore EC, Friedman J, Valdivieso M, Plunkett W, Marti JR, Russ J, Loo TL.
    Biochem Pharmacol; 1982 Oct 15; 31(20):3317-21. PubMed ID: 7150358
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Quantitation of the antitumor agent N-(phosphonacetyl)-L-aspartic acid in human plasma and urine by gas chromatography-mass spectrometry-selected ion monitoring.
    Branfman AR, Bruni RJ, Merrill YN, Chadwick M, Strong JM, Ervin TJ.
    J Chromatogr; 1980 May 09; 182(2):163-9. PubMed ID: 7380909
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Determination of N-(phosphonacetyl)-L-aspartic acid (PALA) in plasma and urine by high pressure liquid chromatography.
    Lankelma J, Penders PG, Leyva A, Pinedo HM.
    Eur J Cancer (1965); 1980 Nov 09; 16(11):1483-7. PubMed ID: 7227423
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.